Oxford GlycoSciences Old Proteomics Team Founds New Company: Oxford Genome Sciences | GenomeWeb

Following Oxford GlycoSciences’ closing of its proteomics division after it was acquired by Celltech in December 2003, members of the Oxford Glycosciences’ old proteomics team have decided to launch a company of their own called Oxford Genome Sciences.

Registered last December in the United Kingdom, the company’s primary focus is to help customers, such as pharmaceutical companies, to discover biomarkers and protein targets and to validate biomarkers and drug targets.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

In Nature this week: genetic history of HIV in the US, and more.

There are a few projects aimed at addressing the lack of diversity in genomic research, Technology Review reports.

A national assessment shows that US students lag in the sciences, but suggests that achievement gaps are narrowing.

Harvard's George Church discusses HGP-write with the Journal of the American Medical Association.